28
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Insulin Receptor Gene in Hypertension

Pages 551-565 | Published online: 03 Jul 2009

References

  • Ying L. H., Zee R. Y.L., Griffiths L. R., Morris B. J. Association of a RFLP for the insulin receptor gene, but not insulin, with essential hypertension. Biochem Biophys Res Commun 1991; 181: 486–492
  • Seino S., Seino M., Bell G. I. Human insulin-receptor gene. Partial sequence and amplification of exons by polymerase chain reaction. Diabetes 1990; 39: 123–128
  • Morris B. J., Zee R. Y.L., Ying L. H., Griffiths L. R. Independent, marked associations of alleles of the insulin receptor and dipeptidyl carboxypeptidase-1 genes with essential hypertension. Clin Sci 1993; 85: 189–195
  • Zee R. Y.L., Lou Y. K., Morris B. J. Insertion variant in intron 9, but not microsatellite in intron 2, of the insulin receptor gene is associated with essential hypertension. J Hypertens 1993; 11: 1283–1288
  • Zee R. Y.L., Lou Y. K., Morris B. J. Insertion variant in intron 9, but not microsatellite in intron 2, of the insulin receptor gene is associated with essential hypertension. J Hypertens 1994; 12(suppl 7)S13–S13
  • Seino S., Seino M., Nishi S., Bell G. I. Structure of the human insulin receptor gene and characterization of its promoter. Proc Natl Acad Sci USA 1989; 86: 114–118
  • Zee R. Y.L., Griffiths L. R., Morris B. J. Marked association of a RFLP for the low density lipoprotein receptor gene with obesity in essential hypertensives. Biochem Biophys Res Commun 1992; 189: 965–971
  • Zee R. Y.L., Schrader A. P., Robinson B. G., Griffiths L. R., Morris B. J. Association of Hincll RFLP of low density lipoprotein receptor gene with obesity in essential hypertensives. Clin Genet 1995; 47: 118–121
  • Schrader A. P., Zee R. Y.L., Morris B. J. Association analyses of Nsil RFLP of human insulin receptor gene in hypertensives. Clin Genet 1996; 49: 74–78
  • Qiu C., Ji T. Detection of mutation in insulin receptor gene in patients with essential hypertension. Acta Acad Med Sincae 1995; 17: 81–85
  • Fujioka Y., Takekawa K., Nakagawa Y., Hamada Y., Ikegami H., Yamato E., Fujisawa T., Ueda H., Miki T., Ogihara T. Insulin receptor gene polymorphism and hyperinsulinemia in hypertensive patients. Hypertens Res 1995; 18: 215–218
  • Ikegami H., Yamato E., Fujisawa T., Hamada Y., Fujioka Y., Rakugi H., Higaki J., Murakami H., Shimamoto K., Ogihara T. Analysis of candidate genes for insulin resistance in essential hypertension. Hypertens Res 1996; 19(Suppl. I)S31–S31
  • Hein H. O., Sørensen H., Saudicani P., Gyntelberg F. The Lewis blood group — a new genetic marker of ischaemic heart disease. J Internal Med 1992; 232: 481–487
  • McClain D. A., Henry R. R., Ullrich A., Olefsky J. M. Restriction-fragment-length polymorphism in insulin resistance in NIDDM. Diabetes 1988; 37: 1071–1075
  • Munroe P. B., Emilion G., Daniel H., Christie K., Lawson M., Boulox P., Caulfield M. Haplotype analysis of the insulin receptor (INSR) gene in human essential hypertension (EH). (Abstract). J Hypertens 1994; 12(suppl. 3)S168
  • Ying L. H., Zee R. Y.L., Griffiths L. R., Morris B. J. Non-linkage of insulin receptor locus with essential hypertension in an affected pedigree. Hypertens Res 1993; 16: 25–28
  • Jeunemaitre X., Soubrier F., Kotelevtsev Y. V., Lifton R. P., Williams C. S., Charru A., Hunt S. C., Hopkins P. N., Williams R. R., Lalouel J. M., Corvol P. Molecular basis of human hypertension: Role of angiotensinogen. Cell 1992; 71: 169–180
  • Caulfield M., Lavender P., Farrall M., Munroe P., Lawson M., Turner P., Clark A. J.L. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: 1629–1633
  • Hanis C. L., Boerwinkle E., Chakraborty R., Ellsworth D. L., Concannon P., Stirling B., Morrison V. A., Wapelhorst B., Spielman R. S., Gogolin-Ewens K. J., Shephard J. M., Williams S. R., Risch N., Hinds D., Iwasaki N., Ogata M., Omori Y., Petzold C., Rietzsch H., Schröder H. E. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996; 13: 161–166
  • Risch N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 1990; 46: 229–241
  • Morgan R., Bishop A., Owens D. R., Luzio S. D., Peters J. R., Rees A. Allelic variants at insulin-receptor and insulin gene loci and susceptibility to NIDDM in Welsh population. Diabetes 1990; 39: 1479–1484
  • Krolewski A. S., Krolewski B., Gray M., Stanton V., Warram J. H., Housman D. High-frequency DNA sequence polymorphisms in the insulin receptor gene detected by denaturing gradient gel blots. Genomics 1992; 12: 705–709
  • Krolewski A. S., Doria A., Magre J., Warram J. H., Housman D. Molecular genetic approaches to the identification of genes involved in the development of nephropathy in insulin-dependent diabetes mellitus. J Am Soc Nephrol 1992; 3: S9–S17
  • Viberti G. C., Keen H., Wiseman M. J. Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. Br Med J 1987; 295: 515–517
  • Freire M. B.S., Ferreira S. R.G., Vivolo M. A., Oliveira J. M., Zanella M. T. Familial hypertension and albuminuria in normotensive type I diabetic patients. Hypertension 1994; 23(Suppl. I)I-256–I-258
  • Barzilay J., Warram J. H., Bak M., Laffel L. M.B., Canessa M., Krolewski A. S. Predisposition to hypertension: Risk factor for nephropathy and hypertension in IDDM. Kidney Internat 1992; 41: 723–730
  • Trevisan R., Nosadini R., Fioretto P., et al. Clustering of renal, cardiovascular and metabolic risk factors in hypertensive insulin-dependent diabetes withe high sodium-lithium countertransport. Kidney Internat 1992; 41: 855–861
  • Nelson R. G., Pettitt D. J., Baird H. R., Charles M. A., Liu Q. Z., Bennett P. H., Knowler W. C. Pre-diabetic blood pressure predicts urinary albumin excretion after the onset of type-2 (non-insulin-dependent) diabetes-mellitus in Pima indians. Diabetologica 1993; 36: 998–1001
  • Sharma A. M., Ruland K., Spies K. P., Distler A. Salt sensitivity in yound normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hypertens 1991; 9: 329–335
  • Allemann Y., Horber F. F., Colombo M., Ferrari P., Shaw S., Jaeger P., Weidmann P. Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet 1993; 341: 327–331
  • Beatty O. L., Harper R., Sheridan B., Atkinson A. B., Bell P. M. Insulin resistance in offspring of hypertensive parents. Br Med J 1993; 307: 92–96
  • Ohno Y., Suzuki H., Yamakawa H., Nakamura M., Otsuka K., Saruta T. Impaired insulin sensitivity in young, lean normotensive offspring of essential hypertensives: possible role of disturbed calcium metabolism. J Hypertens 1993; 11: 421–426
  • Miura K., Nakagawa H., Nishijo M., Tabata M., Morikawa Y., Senma M., Yoshita K., Ishizaki M., Kawano S. Plasma insulin and blood pressure in normotensive Japanese men with normal glucose tolerance. J Hypertens 1995; 13: 427–432
  • Ohmori S., Kiyohara Y., Kato I., Ohmura T., Iwamoto H., Nakayama K., Nomiyama K., Yoshitake T., Ueda K., Fujishima M. Hyperinsulinaemia and blood pressure in a general Japanese population: the Hisayama Study. J Hypertens 1994; 12: 1191–1197
  • Lind L., Berne C., Lithell H. Prevalence of insulin resistance in essential hypertension. J Hypertens 1995; 13: 1457–1462
  • Yokota C., Ikebuchi M., Suzuki M., Norioka M., Ikeda K., Shinozaki K., Harano Y. Insulin resistance rather than hyperinsulinaemai is more closely associated with essential hypertension. Clin Exp Hypertens 1995; 17: 523–536
  • Sinagra D., Greco D., Scarpitta A. M., Bonaventura V. Blood pressure, insulin secretion and resistance in nonhypertensive and hypertensive obese female subjects. Internat J Obesity 1995; 19: 610–613
  • Phillips D. I.W., Barker D. J.P., Haies C. N., Osmond C. Thinness at birth and insulin resistance in adult life. Diabetologia 1994; 37: 150–154
  • Knutson V. P., Donnelly P. V., Balba Y., Lopezreyes M. Insulin resistance is mediated by a proteolytic fragment of the insulin receptor. J Biol Chem 1995; 270: 24972–24981
  • Seino S., Bell G. I. Alternative splicing of human insulin receptor messenger RNA. Biochem Biophys Res Commun 1989; 159: 312–316
  • McClain D. A. Different ligand affinities of the two human insulin receptor splice variants are reflected in parallel changes in sensitivity for insulin action. Mol Endocrinol 1991; 5: 734–739
  • Mosthaf L., Vogt B., Häring H. U., Ullrich A. Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus patients. Proc Natl Acad Sci USA 1991; 88: 4728–4730
  • Kellerer M., Lammers R., Ermel B., Tippmer S., Vogt B., Obermaier-Kusser B., Ullrich A., Häring H. U. Distinct α-subunit structures of human insulin receptor A and B variants determine differences in tyrosine kinase activities. Biochemistry 1992; 31: 4588–4596
  • Vogt B., Carrascosa J. M., Ullrich A., Häring H. The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochem Biophys Res Commun 1991; 177: 1013–1018
  • Sesti G., Marini A. A., Tullio A. N., Montemurro A., Borboni P., Fusco A., Accili D., Lauro R. Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients. Biochem Biophys Res Commun 1991; 181: 1419–1424
  • Kellerer M., Sesti G., Seffer E., Obermaierkusser B., Pongratz D. E., Mosthaf L., Haring H. U. Altered pattern of insulin receptor isotypes in skeletal muscle membranes of type-2 (non-insulin-dependent) diabetic subjects. Diabetologia 1993; 3: 628–632
  • Mosthaf L., Eriksson J., Häring H. U., Groop L., Widen E., Ullrich A. Insulin receptor isotype expression correlates with risk of non-insulin-dependent diabetes. Proc Natl Acad Sci USA 1993; 90: 2633–2635
  • Norgren S., Zierath J., Galuska D., Wallberg-Henriksson H., Luthman H. Differences in the ratio of RNA encoding two isoforms of the insulin receptor between control and NIDDM patients. Diabetes 1993; 42: 675–681
  • Kosaki A., Webster N. J.G. Effect of dexamethasone on the alternative splicing of the insulin receptor messenger RNA and insulin action in HepG2 hepatoma cells. J Biol Chem 1993; 268: 21990–21996
  • Norgren S., Li L. S., Luthman H. a:Regulation of human insulin receptor RNA splicing in HepG2 cells — effects of glucocorticoid and low glucose concentration. Biochem Biophys Res Commun 1994; 19: 277–284
  • Norgren S., Zierath J., Wedell A., Wallberghenriksson H., Luthman H. Regulation of human insulin receptor RNA splicing in vivo. Proc Natl Acad Sci USA 1994; 91: 1465–1469
  • Green M. R. Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. Ann Rev Cell Biol 1991; 7: 559–599
  • Lou Y. K., Zee R. Y.L., Morris B. J. No difference in the proportion of insulin receptor exon 11+/- isoform mRNA in the liver of rats after development of hypertension. Clin Exp Pharmacol Physiol 1996; 23: 564–566
  • Nolan J. J., Freidenberg G., Henry R., Reichart D., Olefsky J. M. Role of human skeletal muscle insulin receptor kinase in the in vivo insulin resistance of noninsulin-dependent diabetes mellitus and obesity. J Clin Endocrinol Metab 1994; 78: 471–477
  • Hanberg A., Vaag A., Vinten J., Becknielsen H. Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type-2 (non-insulin-dependent) diabetes-mellitus. Diabetologia 1993; 36: 668–674
  • Flack J. M., Sowers J. R. Epidemiological and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med 1991; 91(suppl. 1A)11S–21S
  • Standley P. R., Zhang F., Ram J. L., Zemel M. B., Sowers J. R. Insulin attenuates vasopressin-induced calcium transients and a voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest 1991; 88: 1230–1236
  • Morris B. J. Identification of essential hypertension genes. (Editorial review). J Hypertens 1993; 11: 115–120
  • Sanchez-Margalet V., Valle M., Lobón J. A., Maldonado A., Escobar F., Pérez R., Goberna R. Diminished insulin receptors on erythrocyte ghosts in nonobese patients with essential hypertension independent of hyperinsulinemia. J Cardiovasc Pharmacol 1994; 24: 74–77
  • Sechi L. A., Griffin C. A., Schambelan M. Effect of dietary sodium chloride on insulin receptor number and mRNA levels in rat kidney. Am J Physiol 1994; 266: F31–F38
  • Mondon C. E., Reaven G. M. Evidence for abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism 1988; 37: 303–305
  • Swislocki A., Tsuzuki A. Insulin resistance and hypertension: Glucose intolerance, hyperinsulinaemia, and elevated free fatty acids in the lean spontaneously hypertensive rat. Am J Med Sci 1993; 30: 282–286
  • Sechi L. A., Griffin C. A., Griffin G., Griffin G., Zingaro L., Catena C., Bartoli E., Schambelan M. Abnormalities of insulin receptors in spontaneously hypertensive rats. Hypertension 1996; 27: 955–961
  • Lee J. K., Tsai S. Y. Multiple hormone response elements can confer glucocorticoid regulation on the human insulin receptor gene. Mol Endocrinol 1994; 8: 625–634
  • Chen H., Walker G. E., Taylor S. I., McKeon C. Proximal enhancer of the human insulin receptor gene binds the transcription factor Sp1. Diabetes 1994; 43: 884–889
  • Webster N. J.G., Resnik J. L., Reichart D. B., Strauss B., Haas M., Seely B. L. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: A possible mechanism for receptor overexpression in breast cancer. Cancer Res 1996; 56: 2781–2788
  • Brunetti A., Brunetti L., Foti D., Accili D., Goldfine I. D. Human diabetes associated with defects in nuclear regulatory proteins for the insulin receptor gene. J Clin Invest 1996; 97: 258–262
  • Swislocki A. Insulin resistance and hypertension. Am J Med 1990; 299: 104–115
  • DeFronzo R. A., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia, and atherosclerotic disease. Diabetes Care 1991; 14: 173–194
  • Reaven G. M. Insulin resistance and compensatory hyperinsulinemia: Role in hypertension, dyslipidemia, and coronary heart disease. Am Heart J 1991; 121: 1283–1288
  • Brands M. W., Hall J. E. Insulin resistance, hyperinsulinaemia, and obesity-associated hypertension. J Am Soc Nephrol 1992; 3: 1064–1077
  • Morris A. D., Petrie J. R., McConnell M. C. Insulin and hypertension. J Hypertens 1994; 12: 633–642
  • Young A. A., Rink T. J., Vine W., Gedulin B. Amylin and Syndrome-X. Drug Devel Res 1994; 32: 90–99
  • Cooper M. E., McNally P. G., Phillips P. A., Johnston C. I. Amylin stimulates plasma renin concentration in humans. Hypertension 1995; 26: 460–464
  • Walker W. G., Whelton P. K., Saito H., Russell R. P., Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979; 1: 287–291
  • Bennett C. L., Schrader A. P., Morris B. J. Cross-sectional analysis of Met235Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun 1993; 197: 833–839
  • Cassis L. A., Saye J. A., Peach M. J. Location and regulation of rat angiotensinogen messenger RNA. Hypertension 1988; 11: 591–596
  • Murakami E., Hiwada K., Kokubu T. Effects of insulin and glucagon on production of renin substrate by the isolated rat liver. J Endocrinol 1980; 85: 151–153

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.